GlaxoSmithKline Plc. – GSK: Removed from Watch List. An undisclosed SEC investigation we previously warned about has now been disclosed. However, investors should be on guard regarding China. We see confusing disclosures that you need to explore if you have an interest in this company. Full details in today’s report.
To access the SEC Investigation Update, which includes our full research history on this company, click on the PDF (only visible when logged-in).
This article is premium content. To continue reading, please Sign In or Join at the top of this page.
